Physician profile
Mark L Johnson
NPI 1649353855
$952.12
in general payments reported to CMS, 2019-2025
9 companies · $66.96 in 2025
The $66.96 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $37.72 · 2021: $19.97 · 2022: $262 · 2023: $103 · 2024: $46.33 · 2025: $66.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $539.20 | 2019-2023 | Da Vinci Surgical System |
| Conmed Corporation | $89.45 | 2022 | |
| Janssen Pharmaceuticals, INC | $72.99 | 2022-2023 | Xarelto |
| Dilon Technologies, INC. | $66.96 | 2025 | Hemoblast Bellows |
| Davol INC. | $50.77 | 2022 | |
| Allergan, INC. | $47.65 | 2019-2022 | |
| Medtronic, INC. | $42.48 | 2024 | Sonicision |
| Merck Sharp & Dohme LLC | $38.77 | 2020-2021 | |
| Kerecis Limited | $3.85 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.